STOCK TITAN

Cycclone Inc Stock Price, News & Analysis

CDBT OTC

Welcome to our dedicated page for Cycclone news (Ticker: CDBT), a resource for investors and traders seeking the latest updates and insights on Cycclone stock.

China Dasheng Biotechnology Co (CDBT) drives innovation in sustainable technology through its development of low-carbon emission engines and clean energy solutions. This news hub provides investors and industry observers with essential updates on corporate developments, strategic partnerships, and technological advancements.

Access timely updates on CDBT's progress in reducing industrial carbon footprints, including acquisition activity and operational milestones. The company's recent expansion through strategic acquisitions demonstrates its commitment to scaling environmentally conscious technologies.

This resource consolidates official press releases regarding technology patents, executive leadership updates, and international business developments. Users will find verified information about CDBT's engineering breakthroughs and corporate governance matters.

Bookmark this page for direct access to primary source materials from China Dasheng Biotechnology Co. Check regularly for updates on clean technology innovations and business strategy implementations shaping CDBT's environmental impact initiatives.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

China Dasheng Biotechnology Co. (CDBT) has signed a Share Exchange Agreement to acquire all outstanding shares of Cycclone Magnetic Engines, Inc. (CME). This acquisition consolidates CDBT’s control over CME, providing full ownership of intellectual property, assets, and equipment associated with Cycclone Magnetic Engines. CME, founded in January 2005, specializes in low carbon emission engines and clean technology solutions. The merger will result in a rebranding of CDBT to Cycclone Magnetic Engines, Inc. The integration aims to enhance operational efficiency and reduce greenhouse emissions, reflecting the company's commitment to shareholders and sustainable practices. CDBT's CEO, Micheal Nugent, highlighted the strategic importance of this acquisition in realizing the vision of its founders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.06%
Tags
Rhea-AI Summary

China Dasheng Biotechnology Co. (OTC PINK:CDBT) reported on April 20, 2023, an incident involving embezzlement by former operations manager Cameron James Smith at their transport unit, Roadbees Transport Pty Ltd. In late December 2021, Smith misled clients into depositing funds into his personal accounts by falsely claiming that company accounts were compromised. His actions were flagged within 17 days, leading to a swift investigation.

Queensland Police are now involved, confirming allegations of impropriety. The company emphasized the effectiveness of their accounting systems in detecting suspicious conduct. Additionally, the company is progressing on a share exchange agreement with Cycclone Magnetic Engine Developments, focusing on low carbon emission technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

China Dasheng Biotechnology Co. (OTC PINK:CDBT) announced a significant development with its subsidiary, Cycclone Magnetic Engines, securing a work order for the production of the new Y9XM engine.

Manufacturing will take place across three facilities in Australia. The initial target is to produce 50 engines for testing in stationary power applications, particularly for agricultural needs.

The company aims to achieve market certification and compliance for its engines, paving the way for future commercial opportunities. This advancement highlights CDBT's commitment to developing low-carbon emission technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Cycclone Magnetic Engines, formerly China Dasheng Biotechnology Co. (OTC PINK:CDBT), is recognized in Global Business Leaders Magazine's "20 Leading Companies of the Year 2023." This acknowledgment follows the company’s transition into the public market, aiming to overcome prior challenges related to its unproven technology. Under CEO Micheal Nugent’s leadership, the company is focused on designing engines powered by permanent magnets. Despite facing legal hurdles, Cycclone aims to produce 3D models and conduct open testing on new engine prototypes, with a vision for commercial production in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.58%
Tags
none
Rhea-AI Summary

China Dasheng Biotechnology Co. (OTC PINK:CDBT) is set to be renamed Cycclone Magnetic Engine Developments, Inc. after leasing two industrial properties in Bangalow, New South Wales. This strategic move aims to bolster their component development operations for the new Cycclone Y9MX engine, featuring advanced technology like a staggered crank and 18 powerful magnets. The project will also see the filing of patents, which had been delayed due to various challenges. Furthermore, efforts to close a merger with a custodian rescue company are ongoing, and the company is preparing to return to full reporting as an audited filer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.69%
Tags
none

FAQ

What is the current stock price of Cycclone (CDBT)?

The current stock price of Cycclone (CDBT) is $0.044 as of May 8, 2025.

What is the market cap of Cycclone (CDBT)?

The market cap of Cycclone (CDBT) is approximately 1.2M.
Cycclone Inc

OTC:CDBT

CDBT Rankings

CDBT Stock Data

1.23M
25.17M
Shell Companies
Financial Services
China
Lanzhou